Search results
Results from the WOW.Com Content Network
A recent study found that a class of medications called SGLT-2 inhibitors—which does not include Ozempic or similar drugs like Zepbound—significantly lowered the risk of dementia in people ...
However, semaglutide tamps down inflammation, lowering the risk of obesity and heart disease—which are risk factors for developing dementia and Alzheimer’s disease, Dr. Porter says.
With Ozempic for kids seemingly on the horizon, we sat down with a pediatrician, obesity expert, pediatric endocrinologist and adolescent psychiatrist to talk about the benefits and risks of ...
Doctors prescribe Ozempic to people who have type 2 diabetes, whereas Wegovy is typically geared towards people with obesity or people who have a body mass index (BMI) of 27 or higher, signifying ...
A 2024 study published in Alzheimer's & Dementia suggests that semaglutide may help reduce the risk of Alzheimer's disease. [59] Researchers analyzed three years of electronic medical records from over 1 million patients with Type 2 diabetes who had not been previously diagnosed with Alzheimer's and had at least one additional cardiometabolic ...
Ozempic can also cause gastrointestinal symptoms like diarrhea and vomiting that could lead to dehydration and confusion, he says. “These would be indirect effects, though,” Dr. Merrill says.
GLP-1 drugs such as Wegovy and Ozempic (semaglutide) and Zepbound (tirzepatide) may offer benefits that extend beyond aiding in weight loss in people who have type 2 diabetes or obesity ...
The study found Ozempic, or semaglutide, was not tied to a higher risk of any of the neurological or psychiatric conditions studied, such as anxiety or depression, and patients taking Ozempic had lowe